CELIMAX PORE SKIN CLARIFYING DAILY SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene cream

Drug Labeling and Warnings

Drug Details [pdf]

Actiove ingredients

AVOBENZONE 2.7%
HOMOSALATE 13.6%
OCTISALATE 4.5%
OCTOCRYLENE 9%

Purpose

SUNSCREEN

Uses

helps prevent sunburn if used as directed with other sun

protection measures (see Directions) decreases the risk of skin

cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use

on damaged skin or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use

and ask a doctor if rash occurs

Keep out of reach

of children If swallowed, get medical help or contact a Poison Control Center right away.

Directions

■ apply liberally 15 minutes before sun exposure.

Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

limit time in the sun, especially from 10 a.m. - 2 p.m.

wear long-sleeved shirts, pants, hats, and sunglasses

■ children under 6 months of age: Ask a doctor

■ reapply at least every 2 hours

■ use a water-resistant sunscreen if swimming or sweating

Other information

■ protect the product from excessive heat and direct sun ■ Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

WATER, NIACINAMIDE, BUTYLOCTYL SALICYLATE, PROPANEDIOL, POLYMETHYLSILSESQUIOXANE, C20-22 ALKYL PHOSPHATE, C20-22 ALCOHOLS, 1,2-HEXANEDIOL, PENTYLENE GLYCOL, PANTHENOL, METHYL TRIMETHICONE, TRANEXAMIC ACID, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, GLYCERYL STEARATE, VP/EICOSENE COPOLYMER, TROMETHAMINE, POLYACRYLATE CROSSPOLYMER-6, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, SILICA, BUTYLENE GLYCOL, ETHYLHEXYLGLYCERIN, METHYLPROPANEDIOL, POLYETHER-1, TOCOPHEROL, POLYGLYCERYL-4 ISOSTEARATE, CAPRYLIC/CAPRIC TRIGLYCERIDE, DISTEARDIMONIUM HECTORITE, BIOSACCHARIDE GUM-1, ERIOBOTRYA JAPONICA LEAF EXTRACT, MENTHA VIRIDIS (SPEARMINT) EXTRACT, QUERCETIN

PACKAGE LABEL PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CELIMAX PORE SKIN CLARIFYING DAILY SUNSCREEN 
avobenzone, homosalate, octisalate, octocrylene cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87226-150
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	6.8 g  in 50 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	2.3 g  in 50 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	1.4 g  in 50 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	4.5 g  in 50 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)
PROPANEDIOL (UNII: 5965N8W85T)
POLYACRYLATE CROSSPOLYMER-6 (UNII: Q7UI015FF9)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
BIOSACCHARIDE GUM-1 (UNII: BB4PU4V09H)
METHYLPROPANEDIOL (UNII: N8F53B3R4R)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
C20-22 ALCOHOLS (UNII: O4M0347C6A)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
PANTHENOL (UNII: WV9CM0O67Z)
METHYL TRIMETHICONE (UNII: S73ZQI0GXM)
SILICA (UNII: ETJ7Z6XBU4)
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U)
QUERCETIN (UNII: 9IKM0I5T1E)
NIACINAMIDE (UNII: 25X51I8RD4)
MENTHA SPICATA WHOLE (UNII: O2H83I4PUN)
TRANEXAMIC ACID (UNII: 6T84R30KC1)
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
C20-22 ALKYL PHOSPHATE (UNII: L4VKP0Y7RP)
TROMETHAMINE (UNII: 023C2WHX2V)
TOCOPHEROL (UNII: R0ZB2556P8)
ERIOBOTRYA JAPONICA LEAF (UNII: Z02066SV11)
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87226-150-02	1 in 1 BOX	04/07/2026
1	NDC: 87226-150-01	50 mL in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	04/07/2026

Labeler - ABSORBLAB Co., Ltd (694775741)

Establishment
Name	Address	ID/FEI	Business Operations
Kolmar Korea Co., Ltd		963271745	manufacture(87226-150)